Illumina deal for Grail could hurt innovation, EU warns – Reuters
The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike BlakeBRUSSELS, July 22 (Reuters) – U.S. life sciences company Illumina Inc’s (ILMN.O) proposed acquisition of cancer test maker Grail Inc…
